MyFinsight
Home
Blog
About
Contact
Download
Download image
Maturities of marketable
securities
$25,000K
Proceeds from exercise of
stock options
$378K
Cash received from
held for sale assets
$5K
Net cash provided by
investing activities
$8,447K
Net cash provided by
financing activities
$378K
Canceled cashflow
$16,558K
Net decrease in
cash, cash...
-$1,732K
Canceled cashflow
$8,825K
Other long-term
assets
-$2,787K
Stock-based compensation
$1,768K
Accrued expenses and
other current...
$1,592K
Accounts payable
$403K
Non-cash interest
expense
$193K
Foreign exchange
remeasurement gain
-$134K
Accretion on invested
securities
-$111K
Non-cash lease expense
$71K
Depreciation
$12K
Acquired in-process
research and development
$10,000K
Purchase of marketable
securities
$6,558K
Net cash used in
operating activities
-$10,557K
Canceled cashflow
$7,071K
Net loss
-$13,587K
Accrued rent receivable
$3,093K
Prepaid expenses and
other current assets
$897K
Operating lease
liabilities
-$51K
Back
Back
Cash Flow
source: myfinsight.com
Instil Bio, Inc. (TIL)
Instil Bio, Inc. (TIL)